Page 36 - Genomic Medicine in Emerging Economies

References 25

governments in developing countries. The only way to overcome this situation
is for those who are championing genomic medicine to work toward a World
Health Assembly declaration on genomic medicine, calling on member states
to implement genomic medicine in their countries. That would set the wheels
in motion around the world.

References

Adams, M.C., Evans, J.P., Henderson, G.E., Berg, J.S., 2016. The promise and peril of genomic
screening in the general population. Genet. Med. 18 (6), 593–599.
Bodian, D.L., McCutcheon, J.N., Kothiyal, P., Huddleston, K.C., Iyer, R.K., Vockley, J.G., et al., 2014.
Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: im-
plications for individual genome sequencing. PLoS ONE 9 (4), e94554.
Burton, H., Jackson, C., Abubakar, I., 2014. The impact of genomics on public health practice. Br.
Med. Bull. 112 (1), 37–46.
Castéra, L., Krieger, S., Rousselin, A., Legros, A., Baumann, J.-J., Bruet, O., et al., 2014. Next-gen-
eration sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic
capture targeting multiple candidate genes. Eur. J. Hum. Genet. 22 (11), 1305–1313.
Cohn, E.G., Husamudeen, M., Larson, E.L., Williams, J.K., 2015. Increasing participation in ge-
nomic research and biobanking through community-based capacity building. J. Genet. Couns.
24 (3), 491–502.
De Abrew, A., Dissanayake, V.H.W., Korf, B.R., 2014. Challenges in global genomics education.
Appl. Transl. Genom. 3 (4), 128–129.
Dissanayake, V.H.W., Barash, C.I., 2016. Unsung heroes: genomic successes in the developing
world. Appl. Transl. Genom. 9, 1–2.
Eggington, J.M., Bowles, K.R., Moyes, K., Manley, S., Esterling, L., Sizemore, S., et al., 2014. A com-
prehensive laboratory-based program for classification of variants of uncertain significance in
hereditary cancer genes. Clin. Genet. 86 (3), 229–237.
Etchegary, H., Green, J., Dicks, E., Pullman, D., Street, C., Parfrey, P., 2013. Consulting the community:
public expectations and attitudes about genetics research. Eur. J. Hum. Genet. 21 (12), 1338–1343.
Fluegge, K., 2016. The new frontier in health services research: a behavioural paradigm guided by
genetics. J. Health Serv. Res. Policy.
Goldblatt, E.M., Lee, W.-H., 2010. From bench to bedside: the growing use of translational research
in cancer medicine. Am. J. Transl. Res. 2 (1), 1–18.
Helmy, M., Awad, M., Mosa, K.A., 2016. Limited resources of genome sequencing in developing
countries: challenges and solutions. Appl. Transl. Genom. 9, 15–19.
Hiraki, S., Rinella, E.S., Schnabel, F., Oratz, R., Ostrer, H., 2014. Cancer risk assessment using ge-
netic panel testing: considerations for clinical application. J. Genet. Couns. 23 (4), 604–617.
Isaacson Barash, C., 2016. Translating translational medicine into global health equity: what is
needed? Appl. Transl. Genom. 9, 37–39.
Korf, B.R., Berry, A.B., Limson, M., Marian, A.J., Murray, M.F., O’Rourke, P.P., et al., 2014. Frame-
work for development of physician competencies in genomic medicine: Report of the Compe-
tencies Working Group of the Inter-Society Coordinating Committee for Physician Education
in Genomics. Genet. Med. 16 (11), 804–809.
Madhavan, S., Zenklusen, J.-C., Kotliarov, Y., Sahni, H., Fine, H.A., Buetow, K., 2009. Rembrandt:
helping personalized medicine become a reality through integrative translational research.
Mol. Cancer Res. 7 (2), 157–167.